medigraphic.com
ISSN 1561-3046 (Electronic)

2019, Number 3

<< Back Next >>

Rev Cub Med Mil 2019; 48 (3)

Invasive fungal infection

de Armas GT, Herrera OY, Estrada CM, Castañer MJB

Language: Spanish
References: 15
Page: 630-638
PDF size: 393.44 Kb.


ABSTRACT

Introduction: Invasive fungal infections are almost universally produced by Candida or Aspergillus, but other fungi are identified that require individualized approaches, mainly in immunocompromised patients. Mycetoma is a chronic granulomatous disease, usually limited to the skin and subcutaneous tissue; however, there are localizations such as the thoracic and abdominal, considered of poor prognosis due to a visceral dissemination.
Objective: To show another alternative of visceral dissemination of a mycetoma in a patient who underwent a kidney transplant.
Clinical case: We report the case of a female patient who underwent a kidney transplant from a cadaveric donor. She had a diagnosis of Candida albicans mycetoma in the right arm and lung damage. She had a good response to treatment.
Comments: Invasive fungal infections are becoming more frequent in clinical practice, especially affecting immunosuppressed patients. At present, new drugs are available that are useful in the treatment of these patients, but the prognosis continues to be discouraging in many cases. These infections have the capacity to affect different organs, which determines a serious problem for the patient.


REFERENCES

  1. Lavalle P, Padilla MC. Micosis subcutáneas, Micetoma en PAC DERMA-2. 1ª ed, México: Intersistemas; 2005.

  2. Padilla M, Vidal A. Micetoma en dorso por Nocardia brasiliensis. Comunicación de un caso. Rev Cent Dermatol Pascua. 2004[acceso: 12/02/2016];13(1):33-36. Disponible en: https://www.medigraphic.com/pdfs/derma/cd-2004/cd041h.pdf

  3. Serrano JA, Sandoval AA. El micetoma. Rev Soc Ven Microbiol. 2003; 23(1):70-9.

  4. Acar MR, Padilla Desgarennes MC, Ramos Garibay A, Lara Terrón M. Micetoma de inoculación múltiple por Nocardia brasiliensis. Comunicación de un caso. Rev Cent Dermatol Pascua. 2004[acceso: 12/02/2016]; 13(1):29-32. Disponible en: https://pdfs.semanticscholar.org/49a3/4b62392ab355e8d376fcbb13d742675f33d4.pdf

  5. Timaná Palacios D, Valverde López J, Rojas Plasencia P, Vicuña Ríos D, Díaz Lozano M, Ramírez Moya A. Micetoma: reporte de dos casos en el norte peruano. Dermatol Peru. 2013[acceso: 12/02/2016]; 23(3):163-7 Disponible en: http://sisbib.unmsm.edu.pe/bvrevistas/dermatologia/v23_n3/pdf/a04v23n3.pdf

  6. Bonifaz A. Micetoma, una enfermedad neglecta. Dermatol Rev Mex. 2017 julio[acceso: 16/05/2018]; 61(4):351-354. Disponible en: https://www.medigraphic.com/pdfs/derrevmex/rmd-2017/rmd174m.pdf

  7. Rey Sánchez D, Bernal Vaca L, Linares Linares LY, Parra Giraldo CM, Garzón Erazo JR, Valderrama Beltrán SL, Cañas Arboleda A. Infección fúngica invasiva en pacientes inmunosuprimidos atendidos en un hospital de tercer nivel. Rev Colombiana de Neumología. 2016[acceso: 16/05/2018];28(1):10-6. Disponible en: https://www.researchgate.net/profile/Olga_Chapeton/publication/318467766_Neumo_28_1_28-11_Articulo_CRQ_1/data/596cc5ccaca2728ca689d7f9/Neumo-28-1-28-11-Articulo-CRQ-1.pdf#page=10

  8. Puig-Asensio M, Perman J, Zaragoza R, Gamacho-Montero J, Martin-Mazuelos E, Cuenca-Estrella M, et al. Impact of therapeutic strategies on the prognosis of candidemia in the ICU. Crit Care Med. 2014[acceso: 16/05/2018];42(6):1423-32. Disponible en: https://journals.lww.com/ccmjournal/Fulltext/2014/06000/Impact_of_Therapeutic_Strategies_on_the_Prognosis.14.aspx

  9. Ortiz Ruiz G, Osorio J, Valderrama S, Álvarez D, Elías Díaz R, Calderón J, et al. Risk factors for candidemia in non-neutropenic critical patients in Colombia. Med Intensiva 2016[acceso: 16/05/2018];40(3):139-44. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26725105

  10. McCarty TP, Pappas PG. Invasive candidiasis. Infect Dis Clin North Am. 2016;30:103-24.

  11. Estrada-Barraza D, Dávalos-Martínez A, Flores-Padilla L, et al. Comparación entre métodos convencionales, CHRO Magar Candida y el método de la PCR para la identificación de especies de Candida en aislamientos clínicos. Rev Iberoam Micol. 2011[acceso: 16/05/2018];28:36-42. Disponible en: https://www.chromagar.com/fichiers/1311081840CA_BARRAZA_11.pdf

  12. Ellepola ANB, Morrison CJ. Laboratory diagnosis of invasive candidiasis. J Microbiol. 2005[acceso: 16/05/2018];43:65-84. Disponible en: https://www.researchgate.net/profile/Arjuna_Ellepola/publication/7969636_Laboratory_diagnosis_of_invasive_candidiasis/links/0912f506ac2e32e601000000/Laboratory-diagnosis-of-invasive-candidiasis.pdf

  13. Colombo AL, Cortes JA, Zurita J, Guzman-Blanco M, Alvarado Matute T, de Queiroz Telles, et al. Recommendations for the diagnosis of candidemia in Latin America. Latin America Invasive Mycosis Network. Rev Iberoam Micol. 2013[acceso: 16/05/2018];30(3):150-7. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23764555

  14. Buitrago MJ, Aguado JM, Ballen A, et al. Efficacy of DNA amplification in tissue biopsy samples to improve the detection of invasive fungal disease. Clin Microbiol Infect. 2012[acceso: 16/05/2018];19(6):271-77. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/1469-0691.12110

  15. Arvanitis M, Anagnostou T, Fuchs BB, et al. Molecular and non molecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev. 2014[acceso: 16/05/2018];27(3):490-526. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135902/




2020     |     www.medigraphic.com